Company Filing History:
Years Active: 2008-2013
Title: Diann Blanset: Innovator in Monoclonal Antibody Research
Introduction
Diann Blanset is a prominent inventor based in Hillsborough, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. With a total of 2 patents, her work has implications for therapeutic and diagnostic applications.
Latest Patents
Diann's latest patents focus on isolated human monoclonal antibodies that bind to Anthrax protective antigen. These human antibodies can be produced in non-human transgenic animals, such as transgenic mice, which are capable of producing multiple isotypes of human monoclonal antibodies through V-D-J recombination and isotype switching. Additionally, her patents disclose derivatives of these human antibodies, including bispecific antibodies and immunoconjugates. The patents also cover pharmaceutical compositions that comprise the human antibodies, as well as non-human transgenic animals and hybridomas that produce these antibodies. Furthermore, therapeutic and diagnostic methods for utilizing these human antibodies are also included in her innovative work.
Career Highlights
Diann Blanset is associated with Medarex Inc., where she has been instrumental in advancing research in monoclonal antibodies. Her expertise and innovative approach have positioned her as a key figure in her field.
Collaborations
Diann has collaborated with notable colleagues, including Tibor P Keler and Israel Lowy, contributing to the advancement of research in monoclonal antibodies.
Conclusion
Diann Blanset's contributions to the field of biotechnology, particularly in monoclonal antibody research, highlight her innovative spirit and dedication to advancing medical science. Her work continues to pave the way for new therapeutic and diagnostic methods.